BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29623451)

  • 1. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
    Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
    Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
    Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
    Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
    Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
    J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
    Tetsuka N; Yaguchi T; Machida H; Ito S; Miyairi I
    Pediatr Int; 2017 Mar; 59(3):362-363. PubMed ID: 28317305
    [No Abstract]   [Full Text] [Related]  

  • 6. Invasive Pulmonary Aspergillosis.
    Ledoux MP; Guffroy B; Nivoix Y; Simand C; Herbrecht R
    Semin Respir Crit Care Med; 2020 Feb; 41(1):80-98. PubMed ID: 32000286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus sp. isolated in critically ill patients with extracorporeal membrane oxygenation support.
    Aubron C; Pilcher D; Leong T; Cooper DJ; Scheinkestel C; Pellegrino V; Cheng AC
    Scand J Infect Dis; 2013 Sep; 45(9):715-21. PubMed ID: 23746344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
    J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
    Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E
    Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant.
    Hosseini-Moghaddam SM; Chaparro C; Luong ML; Azad S; Singer LG; Mazzulli T; Rotstein C; Keshavjee S; Husain S
    Transplantation; 2015 Nov; 99(11):2387-93. PubMed ID: 25961491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to invasive pulmonary aspergillosis in critically ill patients.
    Koulenti D; Garnacho-Montero J; Blot S
    Curr Opin Infect Dis; 2014 Apr; 27(2):174-83. PubMed ID: 24514164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pulmonary aspergillosis in patients with influenza infection: A retrospective study and review of the literature.
    Huang L; Zhang N; Huang X; Xiong S; Feng Y; Zhang Y; Li M; Zhan Q
    Clin Respir J; 2019 Apr; 13(4):202-211. PubMed ID: 30661296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Clemons KV; Schwartz JA; Stevens DA
    Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
    Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
    J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
    Spapen H; Spapen J; Taccone FS; Meersseman W; Rello J; Dimopoulos G; Charles PE; Rao R; Pérez M; Martin C; Vogelaers D; Blot SI;
    Int J Antimicrob Agents; 2014 Feb; 43(2):165-9. PubMed ID: 24315314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
    Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.